Since L1CAM is not expressed in normal stem cells and it is present in the bulk population of cancer cells, anti-L1CAM RIT using Auger electrons and alpha-particle emitters would be a promising new option for ovarian CSCs therapy. Here, L1CAM is linked to cancer.